Selected research
Market Structure
Global Automatic Insulin Dose Adjustment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Automatic Insulin Dose Adjustment Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Automatic Insulin Dose Adjustment Software include Glytec, Beta Bionics, Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod and Tempo Platform, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Automatic Insulin Dose Adjustment Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Automatic Insulin Dose Adjustment Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Automatic Insulin Dose Adjustment Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Automatic Insulin Dose Adjustment Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Automatic Insulin Dose Adjustment Software Segment by Company
Glytec
Beta Bionics
Hygieia
Tandem Diabetics
CamDiab
Medtronic
Novo Nordisk
Omnipod
Tempo Platform
Automatic Insulin Dose Adjustment Software Segment by Type
Open-Loop Systems
Closed-Loop Systems
Automatic Insulin Dose Adjustment Software Segment by Application
Subscription Used
One-time Purchase Used
Automatic Insulin Dose Adjustment Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dose Adjustment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dose Adjustment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dose Adjustment Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Automatic Insulin Dose Adjustment Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automatic Insulin Dose Adjustment Software industry.
Chapter 3: Detailed analysis of Automatic Insulin Dose Adjustment Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Automatic Insulin Dose Adjustment Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Open-Loop Systems
- Closed-Loop Systems
Applications
- Subscription Used
- One-time Purchase Used
Companies covered
- Glytec
- Beta Bionics
- Hygieia
- Tandem Diabetics
- CamDiab
- Medtronic
- Novo Nordisk
- Omnipod
- Tempo Platform
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Open-Loop Systems
- 1.2.3 Closed-Loop Systems
- 1.3 Market Analysis by Application
- 1.3.1 Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Subscription Used
- 1.3.3 One-time Purchase Used
- 1.4 Global Market Growth Prospects
- 1.5 Global Automatic Insulin Dose Adjustment Software Growth Trends by Region
- 1.5.1 Global Automatic Insulin Dose Adjustment Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Automatic Insulin Dose Adjustment Software Market Size by Region (2021-2026)
- 1.5.3 Automatic Insulin Dose Adjustment Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Automatic Insulin Dose Adjustment Software Market Dynamics
- 2.1 Automatic Insulin Dose Adjustment Software Industry Trends
- 2.2 Automatic Insulin Dose Adjustment Software Industry Drivers
- 2.3 Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges
- 2.4 Automatic Insulin Dose Adjustment Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Automatic Insulin Dose Adjustment Software Revenue by Company (2021-2026)
- 3.2 Global Automatic Insulin Dose Adjustment Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Automatic Insulin Dose Adjustment Software Key Company Head office and Area Served
- 3.4 Global Automatic Insulin Dose Adjustment Software Company, Product Type & Application
- 3.5 Global Automatic Insulin Dose Adjustment Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Automatic Insulin Dose Adjustment Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Automatic Insulin Dose Adjustment Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Automatic Insulin Dose Adjustment Software Tier 1, Tier 2, and Tier 3
4 Automatic Insulin Dose Adjustment Software Market by Type
- 4.1 Global Automatic Insulin Dose Adjustment Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2032)
- 4.3 Global Automatic Insulin Dose Adjustment Software Market Size Share by Type (2021-2032)
5 Automatic Insulin Dose Adjustment Software Market by Application
- 5.1 Global Automatic Insulin Dose Adjustment Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2032)
- 5.3 Global Automatic Insulin Dose Adjustment Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Glytec
- 6.1.1 Glytec Company Information
- 6.1.2 Glytec Business Overview
- 6.1.3 Glytec Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Glytec Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.1.5 Glytec Recent Developments
- 6.2 Beta Bionics
- 6.2.1 Beta Bionics Company Information
- 6.2.2 Beta Bionics Business Overview
- 6.2.3 Beta Bionics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.2.5 Beta Bionics Recent Developments
- 6.3 Hygieia
- 6.3.1 Hygieia Company Information
- 6.3.2 Hygieia Business Overview
- 6.3.3 Hygieia Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.3.5 Hygieia Recent Developments
- 6.4 Tandem Diabetics
- 6.4.1 Tandem Diabetics Company Information
- 6.4.2 Tandem Diabetics Business Overview
- 6.4.3 Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.4.5 Tandem Diabetics Recent Developments
- 6.5 CamDiab
- 6.5.1 CamDiab Company Information
- 6.5.2 CamDiab Business Overview
- 6.5.3 CamDiab Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.5.5 CamDiab Recent Developments
- 6.6 Medtronic
- 6.6.1 Medtronic Company Information
- 6.6.2 Medtronic Business Overview
- 6.6.3 Medtronic Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.6.5 Medtronic Recent Developments
- 6.7 Novo Nordisk
- 6.7.1 Novo Nordisk Company Information
- 6.7.2 Novo Nordisk Business Overview
- 6.7.3 Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.7.5 Novo Nordisk Recent Developments
- 6.8 Omnipod
- 6.8.1 Omnipod Company Information
- 6.8.2 Omnipod Business Overview
- 6.8.3 Omnipod Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.8.5 Omnipod Recent Developments
- 6.9 Tempo Platform
- 6.9.1 Tempo Platform Company Information
- 6.9.2 Tempo Platform Business Overview
- 6.9.3 Tempo Platform Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.9.5 Tempo Platform Recent Developments
7 North America
- 7.1 North America Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 7.2 North America Automatic Insulin Dose Adjustment Software Market Size by Type
- 7.2.1 North America Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2026)
- 7.2.2 North America Automatic Insulin Dose Adjustment Software Market Size by Type (2027-2032)
- 7.2.3 North America Automatic Insulin Dose Adjustment Software Market Share by Type (2021-2032)
- 7.3 North America Automatic Insulin Dose Adjustment Software Market Size by Application
- 7.3.1 North America Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2026)
- 7.3.2 North America Automatic Insulin Dose Adjustment Software Market Size by Application (2027-2032)
- 7.3.3 North America Automatic Insulin Dose Adjustment Software Market Share by Application (2021-2032)
- 7.4 North America Automatic Insulin Dose Adjustment Software Market Size by Country
- 7.4.1 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 7.4.3 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 7.4.4 North America Automatic Insulin Dose Adjustment Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 8.2 Europe Automatic Insulin Dose Adjustment Software Market Size by Type
- 8.2.1 Europe Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2026)
- 8.2.2 Europe Automatic Insulin Dose Adjustment Software Market Size by Type (2027-2032)
- 8.2.3 Europe Automatic Insulin Dose Adjustment Software Market Share by Type (2021-2032)
- 8.3 Europe Automatic Insulin Dose Adjustment Software Market Size by Application
- 8.3.1 Europe Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2026)
- 8.3.2 Europe Automatic Insulin Dose Adjustment Software Market Size by Application (2027-2032)
- 8.3.3 Europe Automatic Insulin Dose Adjustment Software Market Share by Application (2021-2032)
- 8.4 Europe Automatic Insulin Dose Adjustment Software Market Size by Country
- 8.4.1 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 8.4.3 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 8.4.4 Europe Automatic Insulin Dose Adjustment Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 9.2 China Automatic Insulin Dose Adjustment Software Market Size by Type
- 9.2.1 China Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2026)
- 9.2.2 China Automatic Insulin Dose Adjustment Software Market Size by Type (2027-2032)
- 9.2.3 China Automatic Insulin Dose Adjustment Software Market Share by Type (2021-2032)
- 9.3 China Automatic Insulin Dose Adjustment Software Market Size by Application
- 9.3.1 China Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2026)
- 9.3.2 China Automatic Insulin Dose Adjustment Software Market Size by Application (2027-2032)
- 9.3.3 China Automatic Insulin Dose Adjustment Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 10.2 Asia Automatic Insulin Dose Adjustment Software Market Size by Type
- 10.2.1 Asia Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2026)
- 10.2.2 Asia Automatic Insulin Dose Adjustment Software Market Size by Type (2027-2032)
- 10.2.3 Asia Automatic Insulin Dose Adjustment Software Market Share by Type (2021-2032)
- 10.3 Asia Automatic Insulin Dose Adjustment Software Market Size by Application
- 10.3.1 Asia Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2026)
- 10.3.2 Asia Automatic Insulin Dose Adjustment Software Market Size by Application (2027-2032)
- 10.3.3 Asia Automatic Insulin Dose Adjustment Software Market Share by Application (2021-2032)
- 10.4 Asia Automatic Insulin Dose Adjustment Software Market Size by Country
- 10.4.1 Asia Automatic Insulin Dose Adjustment Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 10.4.3 Asia Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 10.4.4 Asia Automatic Insulin Dose Adjustment Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Automatic Insulin Dose Adjustment Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst